Further, plaintiffs say, all U.S. purchasers of those Dannon brands are entitled to compensation and the company needs to launch "a corrective advertising campaign."
Dannon spokesman Michael Neuwirth says his firm is not yet familiar with the suit, but stands by "the claims of our products and the clinical studies which support them."
Activia, launched in the United States in 2006, says it contains a trademarked bacteria called "Bifidus regularis" to help "naturally regulate your digestive system." But the suit cites scientific research showing that there is no conclusive evidence that "Bifidus regularis" prevents illness or is beneficial to healthy adults -- and claims Dannon knew that.
advertisement
advertisement